Marco Ruella, MD

Marco Ruella, MD, an assistant professor of medicine (hematology-oncology) in the Department of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies at the University of Pennsylvania Perelman School of Medicine; as well as the scientific director of the Lymphoma Program at the Hospital of the University of Pennsylvania

Articles by Marco Ruella, MD

Dr Ruella on the Importance of Clinical Trial and Treatment Accessibility for Myeloma

ByMarco Ruella, MD

March 10th 2025

Marco Ruella, MD, discusses ways to develop accessible cancer treatments to more greatly benefit diverse populations of patients with multiple myeloma.

Dr Ruella on Improving Access to CAR T-Cell Therapy for Minority Populations in Multiple Myeloma

ByMarco Ruella, MD

January 15th 2025

Marco Ruella, MD, discusses strategies to improve access to CAR T-cell therapy for the management of multiple myeloma in minority health populations.

Dr Ruella on Access Disparities to CAR T-Cell Therapy in Minority Patients With Myeloma

ByMarco Ruella, MD

January 14th 2025

Marco Ruella, MD, discusses disparities in access to commercial anti-BCMA CAR T-cell therapy among minority populations (MHPs) with multiple myeloma.

Marco Ruella, MD

Articles by Marco Ruella, MD

Dr Ruella on the Importance of Clinical Trial and Treatment Accessibility for Myeloma

Dr Ruella on Improving Access to CAR T-Cell Therapy for Minority Populations in Multiple Myeloma

Dr Ruella on Access Disparities to CAR T-Cell Therapy in Minority Patients With Myeloma

Latest Updated Articles

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL